Federated Hermes
URGN icon

Federated Hermes’s UroGen Pharma URGN Stock Holding History

Federated Hermes’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-196
Closed -$4.59K – 2167
2025
Q4 		$4.59K Buy
196
+64
+48% +$1.39K ﹤0.01% 1900
2025
Q3 		$2.63K Buy
+132
New +$2.37K ﹤0.01% 2006
2024
Q1 		– Sell
-11,709
Closed -$176K – 2135
2023
Q4 		$176K Sell
11,709
-1,421
-11% -$18.4K ﹤0.01% 1529
2023
Q3 		$184K Buy
+13,130
New +$211K ﹤0.01% 1534
2018
Q4 		– Sell
-6
Closed -$1K – 2318
2018
Q3 		$1K Buy
+6
New +$279 ﹤0.01% 2220

Other funds holding URGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
JFG
Jefferies Financial Group New York $8.2B AUM 40.95% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $90.6B AUM 36.98% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return